2 results
Approved WMOCompleted
To evaluate the proportion of patients indicating an overall preference via a Patient Preference Questionnaire (PPQ) for either the subcutaneous (SC) or the intravenous (IV) route of rituximab administration.
Approved WMOCompleted
Investigating the effectiveness of tCS on the recovery of neglect in sub-acute ischemic stroke patients suffering from neglect to complement conventional treatment